Influenza vaccination: protecting the most vulnerable

Area of Science:

• Virology
• Immunology
• Public Health

Background:

• Influenza virus causes significant global morbidity and mortality, necessitating annual vaccination.
• Vaccine effectiveness is often reduced in the elderly due to immunosenescence and "original antigenic sin".
• High-risk groups include the elderly, very young, pregnant women, and individuals with chronic health conditions.

Purpose of the Study:

• To review current influenza vaccination strategies and challenges.
• To discuss approaches for improving vaccine efficacy in vulnerable populations, particularly the elderly.
• To highlight ongoing research towards a universal influenza vaccine.

Main Methods:

• Review of current influenza vaccination guidelines and strategies.
• Discussion of immunosenescence and "original antigenic sin" impact on vaccine effectiveness.
• Exploration of alternative vaccination approaches, including high-dose, adjuvant, and community-level vaccination strategies.

Main Results:

• Current UK guidelines recommend specific vaccines based on age and risk factors (e.g., live attenuated nasal spray for young children, adjuvanted inactivated vaccine for adults >65).
• Strategies like high-dose or adjuvant vaccines are employed to enhance protection in the elderly.
• Vaccinating healthcare workers and children can reduce community transmission.

Conclusions:

• Improving influenza vaccine effectiveness, especially in the elderly, remains a key challenge.
• Targeted vaccination strategies and novel vaccine formulations are being developed.
• The pursuit of a universal influenza vaccine offers a promising future for long-term protection.